Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

ABC: A tool to identify SNVs causing allele-specific transcription factor binding from ChIP-Seq experiments.

Bailey SD, Virtanen C, Haibe-Kains B, Lupien M.

Bioinformatics. 2015 May 20. pii: btv321. [Epub ahead of print]

PMID:
25995231
2.

Personalized diagnosis of medulloblastoma subtypes across patients and model systems.

Gendoo DM, Smirnov P, Lupien M, Haibe-Kains B.

Genomics. 2015 May 12. pii: S0888-7543(15)00077-4. doi: 10.1016/j.ygeno.2015.05.002. [Epub ahead of print]

PMID:
25979459
3.

Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas.

Wong P, Hui A, Su J, Yue S, Haibe-Kains B, Gokgoz N, Xu W, Bruce J, Williams J, Catton C, Wunder JS, Andrulis IL, Gladdy R, Dickson B, O'Sullivan B, Liu FF.

Oncotarget. 2015 Apr 23. [Epub ahead of print]

4.

Chromosomal instability as a prognostic marker in cervical cancer.

How C, Bruce J, So J, Pintilie M, Haibe-Kains B, Hui A, Clarke BA, Hedley DW, Hill RP, Milosevic M, Fyles A, Liu FF.

BMC Cancer. 2015 May 6;15(1):361. doi: 10.1186/s12885-015-1372-0.

5.

A network model for angiogenesis in ovarian cancer.

Glass K, Quackenbush J, Spentzos D, Haibe-Kains B, Yuan GC.

BMC Bioinformatics. 2015 Apr 11;16:115. doi: 10.1186/s12859-015-0551-y.

6.

Test set bias affects reproducibility of gene signatures.

Patil P, Bachant-Winner PO, Haibe-Kains B, Leek JT.

Bioinformatics. 2015 Mar 18. pii: btv157. [Epub ahead of print]

PMID:
25788628
7.

CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.

Coroller TP, Grossmann P, Hou Y, Rios Velazquez E, Leijenaar RT, Hermann G, Lambin P, Haibe-Kains B, Mak RH, Aerts HJ.

Radiother Oncol. 2015 Mar;114(3):345-50. doi: 10.1016/j.radonc.2015.02.015. Epub 2015 Mar 4.

PMID:
25746350
8.

Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma.

Bruce JP, Hui AB, Shi W, Perez-Ordonez B, Weinreb I, Xu W, Haibe-Kains B, Waggott DM, Boutros PC, O'Sullivan B, Waldron J, Huang SH, Chen EX, Gilbert R, Liu FF.

Oncotarget. 2015 Feb 28;6(6):4537-50.

9.

APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.

Cescon DW, Haibe-Kains B, Mak TW.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2841-6. doi: 10.1073/pnas.1424869112. Epub 2015 Feb 17.

10.

Medulloblastoma subgroups remain stable across primary and metastatic compartments.

Wang X, Dubuc AM, Ramaswamy V, Mack S, Gendoo DM, Remke M, Wu X, Garzia L, Luu B, Cavalli F, Peacock J, López B, Skowron P, Zagzag D, Lyden D, Hoffman C, Cho YJ, Eberhart C, MacDonald T, Li XN, Van Meter T, Northcott PA, Haibe-Kains B, Hawkins C, Rutka JT, Bouffet E, Pfister SM, Korshunov A, Taylor MD.

Acta Neuropathol. 2015 Mar;129(3):449-57. doi: 10.1007/s00401-015-1389-0. Epub 2015 Jan 21.

PMID:
25689980
11.

ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters.

Bailey SD, Zhang X, Desai K, Aid M, Corradin O, Cowper-Sal Lari R, Akhtar-Zaidi B, Scacheri PC, Haibe-Kains B, Lupien M.

Nat Commun. 2015 Feb 3;2:6186. doi: 10.1038/ncomms7186.

PMID:
25645053
12.

Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer.

Nichols AC, Black M, Yoo J, Pinto N, Fernandes A, Haibe-Kains B, Boutros PC, Barrett JW.

BMC Pharmacol Toxicol. 2014 Nov 27;15:66. doi: 10.1186/2050-6511-15-66.

13.

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.

Fumagalli D, Blanchet-Cohen A, Brown D, Desmedt C, Gacquer D, Michiels S, Rothé F, Majjaj S, Salgado R, Larsimont D, Ignatiadis M, Maetens M, Piccart M, Detours V, Sotiriou C, Haibe-Kains B.

BMC Genomics. 2014 Nov 21;15:1008. doi: 10.1186/1471-2164-15-1008.

14.

Gene regulatory networks and their applications: understanding biological and medical problems in terms of networks.

Emmert-Streib F, Dehmer M, Haibe-Kains B.

Front Cell Dev Biol. 2014 Aug 19;2:38. doi: 10.3389/fcell.2014.00038. eCollection 2014. Review.

15.

Untangling statistical and biological models to understand network inference: the need for a genomics network ontology.

Emmert-Streib F, Dehmer M, Haibe-Kains B.

Front Genet. 2014 Aug 29;5:299. doi: 10.3389/fgene.2014.00299. eCollection 2014.

16.

Functional and genetic analysis of the colon cancer network.

Emmert-Streib F, de Matos Simoes R, Glazko G, McDade S, Haibe-Kains B, Holzinger A, Dehmer M, Campbell F.

BMC Bioinformatics. 2014;15 Suppl 6:S6. doi: 10.1186/1471-2105-15-S6-S6. Epub 2014 May 16.

17.

Quantitative assessment and validation of network inference methods in bioinformatics.

Haibe-Kains B, Emmert-Streib F.

Front Genet. 2014 Jul 16;5:221. doi: 10.3389/fgene.2014.00221. eCollection 2014. No abstract available.

18.

Robust Radiomics feature quantification using semiautomatic volumetric segmentation.

Parmar C, Rios Velazquez E, Leijenaar R, Jermoumi M, Carvalho S, Mak RH, Mitra S, Shankar BU, Kikinis R, Haibe-Kains B, Lambin P, Aerts HJ.

PLoS One. 2014 Jul 15;9(7):e102107. doi: 10.1371/journal.pone.0102107. eCollection 2014.

19.

Enhancing reproducibility in cancer drug screening: how do we move forward?

Hatzis C, Bedard PL, Birkbak NJ, Beck AH, Aerts HJ, Stem DF, Shi L, Clarke R, Quackenbush J, Haibe-Kains B.

Cancer Res. 2014 Aug 1;74(15):4016-23. doi: 10.1158/0008-5472.CAN-14-0725. Epub 2014 Jul 11. Review. Erratum in: Cancer Res. 2014 Sep 15;74(18):5348. Stern, David F [corrected to Stem, David F].

PMID:
25015668
20.

Relevance of different prior knowledge sources for inferring gene interaction networks.

Olsen C, Bontempi G, Emmert-Streib F, Quackenbush J, Haibe-Kains B.

Front Genet. 2014 Jun 24;5:177. doi: 10.3389/fgene.2014.00177. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk